Amenorrhea natural history, complications and prognosis: Difference between revisions
Akshun Kalia (talk | contribs) |
Akshun Kalia (talk | contribs) No edit summary |
||
Line 9: | Line 9: | ||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== | ||
===Natural History=== | ===Natural History=== | ||
*If left untreated, all patients of amenorrhea may progress to develop [[infertility]] and [[osteoporosis]]. | |||
*If left untreated, all patients | |||
*The majority of amenorrhea cases are caused by four conditions, which include [[polycystic ovary syndrome]], [[hypothalamic]] amenorrhea, [[hyperprolactinemia]], and [[ovarian failure]]. | *The majority of amenorrhea cases are caused by four conditions, which include [[polycystic ovary syndrome]], [[hypothalamic]] amenorrhea, [[hyperprolactinemia]], and [[ovarian failure]]. | ||
*[[Polycystic ovary syndrome|Polycystic ovary syndrome (PCOS)]], if left untreated can lead to [[heart disease]] from elevated [[cholesterol]] and increased levels of [[androgens]]. Long periods of not having [[menstrual cycles]] leads to unopposed exposure of [[endometrium]] to [[estrogen]], can result in [[endometrial cancer]].<ref name="pmid26261426">{{cite journal |vauthors=Palomba S, Santagni S, Falbo A, La Sala GB |title=Complications and challenges associated with polycystic ovary syndrome: current perspectives |journal=Int J Womens Health |volume=7 |issue= |pages=745–63 |year=2015 |pmid=26261426 |pmc=4527566 |doi=10.2147/IJWH.S70314 |url=}}</ref> | *[[Polycystic ovary syndrome|Polycystic ovary syndrome (PCOS)]], if left untreated can lead to [[heart disease]] from elevated [[cholesterol]] and increased levels of [[androgens]]. Long periods of not having [[menstrual cycles]] leads to unopposed exposure of [[endometrium]] to [[estrogen]], can result in [[endometrial cancer]].<ref name="pmid26261426">{{cite journal |vauthors=Palomba S, Santagni S, Falbo A, La Sala GB |title=Complications and challenges associated with polycystic ovary syndrome: current perspectives |journal=Int J Womens Health |volume=7 |issue= |pages=745–63 |year=2015 |pmid=26261426 |pmc=4527566 |doi=10.2147/IJWH.S70314 |url=}}</ref> | ||
*In functional ([[hypothalamic]]) amenorrhea, the patient usually reports normal regular [[Menstrual cycles|cycles]] in the past, with sudden interruption of menstrual cycles for more than 3 months. There is almost always a history of [[weight loss]] (severe), excessive [[exercise]], or drastic [[emotional stress]] prior to cessation of [[menstruation]].<ref name="pmid25201001">Meczekalski B, Katulski K, Czyzyk A, Podfigurna-Stopa A, Maciejewska-Jeske M (2014) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=25201001 Functional hypothalamic amenorrhea and its influence on women's health.] ''J Endocrinol Invest'' 37 (11):1049-56. [http://dx.doi.org/10.1007/s40618-014-0169-3 DOI:10.1007/s40618-014-0169-3] PMID: [https://pubmed.gov/25201001 25201001]</ref> | *In functional ([[hypothalamic]]) amenorrhea, the patient usually reports normal regular [[Menstrual cycles|cycles]] in the past, with sudden interruption of menstrual cycles for more than 3 months. There is almost always a history of [[weight loss]] (severe), excessive [[exercise]], or drastic [[emotional stress]] prior to cessation of [[menstruation]].<ref name="pmid25201001">Meczekalski B, Katulski K, Czyzyk A, Podfigurna-Stopa A, Maciejewska-Jeske M (2014) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=25201001 Functional hypothalamic amenorrhea and its influence on women's health.] ''J Endocrinol Invest'' 37 (11):1049-56. [http://dx.doi.org/10.1007/s40618-014-0169-3 DOI:10.1007/s40618-014-0169-3] PMID: [https://pubmed.gov/25201001 25201001]</ref> | ||
Line 24: | Line 16: | ||
*Amenorrhea from [[hyperprolactinemia]] can be caused by [[prolactin]] overproduction or [[dopamine]] suppression, and is mostly seen in middle aged women. Idiopathic [[hyperprolactinemia]] is elevated serum [[prolactin]] level without any [[brain]] lesion or other pathologies.<ref name="pmid2058949">{{cite journal |vauthors=Mattei AM, Severini V, Crosignani PG |title=Natural history of hyperprolactinemia |journal=Ann. N. Y. Acad. Sci. |volume=626 |issue= |pages=130–6 |year=1991 |pmid=2058949 |doi= |url=}}</ref> | *Amenorrhea from [[hyperprolactinemia]] can be caused by [[prolactin]] overproduction or [[dopamine]] suppression, and is mostly seen in middle aged women. Idiopathic [[hyperprolactinemia]] is elevated serum [[prolactin]] level without any [[brain]] lesion or other pathologies.<ref name="pmid2058949">{{cite journal |vauthors=Mattei AM, Severini V, Crosignani PG |title=Natural history of hyperprolactinemia |journal=Ann. N. Y. Acad. Sci. |volume=626 |issue= |pages=130–6 |year=1991 |pmid=2058949 |doi= |url=}}</ref> | ||
===Complications=== | ===Complications=== | ||
*Common complications of amenorrhea are based on the underlying disorder inducing amenorrhea. | *Common complications of amenorrhea are based on the underlying disorder inducing amenorrhea. The majority of amenorrhea cases are caused by four conditions, which include [[polycystic ovary syndrome]], [[hypothalamic]] amenorrhea, [[hyperprolactinemia]], and [[ovarian failure]]. | ||
*Common complications of amenorrhea from [[PCOS]] include: | *Common complications of amenorrhea from [[PCOS]] include: | ||
**[[Endometrial hyperplasia]]/[[Endometrial cancer]] | **[[Endometrial hyperplasia]]/[[Endometrial cancer]] | ||
Line 34: | Line 26: | ||
**[[Miscarriage]] | **[[Miscarriage]] | ||
**[[Infertility]] | **[[Infertility]] | ||
*[[Hyperprolactinemia]] leads to [[galactorrhea]], | *[[Hyperprolactinemia]] leads to [[galactorrhea]], decreased [[libido]], and pregnancy complications. In case of [[prolactin]]-producing [[pituitary adenoma]], massive enlargement of the [[tumor]] may affect [[Vision loss|vision]] and [[pituitary]] function. It can also cause [[osteopenia]] and [[osteoporosis]] in pre-[[menopausal]] women.<ref name="pmid10649820">{{cite journal |vauthors=Sanfilippo JS |title=Implications of not treating hyperprolactinemia |journal=J Reprod Med |volume=44 |issue=12 Suppl |pages=1111–5 |year=1999 |pmid=10649820 |doi= |url=}}</ref> | ||
*Common complications of [[premature ovarian failure]] are [[infertility]], [[osteoporosis]], [[depression]]/[[anxiety]], [[cardiac disease]], and [[dementia]].<ref name="urlPremature ovarian failure - Symptoms and causes - Mayo Clinic">{{cite web |url=http://www.mayoclinic.org/diseases-conditions/premature-ovarian-failure/symptoms-causes/dxc-20255567 |title=Premature ovarian failure - Symptoms and causes - Mayo Clinic |format= |work= |accessdate=}}</ref> | *Common complications of [[premature ovarian failure]] are [[infertility]], [[osteoporosis]], [[depression]]/[[anxiety]], [[cardiac disease]], and [[dementia]].<ref name="urlPremature ovarian failure - Symptoms and causes - Mayo Clinic">{{cite web |url=http://www.mayoclinic.org/diseases-conditions/premature-ovarian-failure/symptoms-causes/dxc-20255567 |title=Premature ovarian failure - Symptoms and causes - Mayo Clinic |format= |work= |accessdate=}}</ref> | ||
*Patients with [[hypothalamic]] (functional) amenorrhea experience various complications, such as [[infertility]], decrease in [[Bone mineral density|bone mineral density (BMD)]], increased risk for [[fracture]] along with [[cardiovascular]] and [[psychological]] problems.<ref name="pmid25201001" /> | *Patients with [[hypothalamic]] (functional) amenorrhea experience various complications, such as [[infertility]], decrease in [[Bone mineral density|bone mineral density (BMD)]], increased risk for [[fracture]], along with [[cardiovascular]] and [[psychological]] problems.<ref name="pmid25201001" /> | ||
*The most important complication of [[premature ovarian failure]] is [[infertility]], that is preventable to some extent with appropriate therapies. [[Bone loss]] and [[Mental disorder|mental problems]] are other complications.<ref name="pmid19196677">{{cite journal| author=Nelson LM| title=Clinical practice. Primary ovarian insufficiency. | journal=N Engl J Med | year= 2009 | volume= 360 | issue= 6 | pages= 606-14 | pmid=19196677 | doi=10.1056/NEJMcp0808697 | pmc=2762081 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19196677 }}</ref> | *The most important complication of [[premature ovarian failure]] is [[infertility]], that is preventable to some extent with appropriate therapies. [[Bone loss]] and [[Mental disorder|mental problems]] are other complications.<ref name="pmid19196677">{{cite journal| author=Nelson LM| title=Clinical practice. Primary ovarian insufficiency. | journal=N Engl J Med | year= 2009 | volume= 360 | issue= 6 | pages= 606-14 | pmid=19196677 | doi=10.1056/NEJMcp0808697 | pmc=2762081 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19196677 }}</ref> | ||
===Prognosis=== | ===Prognosis=== |
Revision as of 20:46, 19 October 2017
Amenorrhea Microchapters |
Patient Information |
---|
Diagnosis |
Treatment |
Case Studies |
Amenorrhea natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Amenorrhea natural history, complications and prognosis |
FDA on Amenorrhea natural history, complications and prognosis |
CDC on Amenorrhea natural history, complications and prognosis |
Amenorrhea natural history, complications and prognosis in the news |
Blogs on Amenorrhea natural history, complications and prognosis |
Risk calculators and risk factors for Amenorrhea natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]
Overview
If left untreated, patients with amenorrhea may progress to develop infertility and osteoporosis. Common complications of amenorrhea are based on underlying disorder that induce amenorrhea. Prognosis is generally excellent and the mortality rate of patients with amenorrhea is approximately less than 1%, generally in brain lesions.
Natural History, Complications, and Prognosis
Natural History
- If left untreated, all patients of amenorrhea may progress to develop infertility and osteoporosis.
- The majority of amenorrhea cases are caused by four conditions, which include polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.
- Polycystic ovary syndrome (PCOS), if left untreated can lead to heart disease from elevated cholesterol and increased levels of androgens. Long periods of not having menstrual cycles leads to unopposed exposure of endometrium to estrogen, can result in endometrial cancer.[1]
- In functional (hypothalamic) amenorrhea, the patient usually reports normal regular cycles in the past, with sudden interruption of menstrual cycles for more than 3 months. There is almost always a history of weight loss (severe), excessive exercise, or drastic emotional stress prior to cessation of menstruation.[2]
- Premature ovarian failure presents with menopause before the age of 40 and elevated levels of gonadotropins. In the age group of 41 to 44 years, it is called pre-menopause. Patients of Premature ovarian failure generally have a family history of ovarian failure.[3]
- Amenorrhea from hyperprolactinemia can be caused by prolactin overproduction or dopamine suppression, and is mostly seen in middle aged women. Idiopathic hyperprolactinemia is elevated serum prolactin level without any brain lesion or other pathologies.[4]
Complications
- Common complications of amenorrhea are based on the underlying disorder inducing amenorrhea. The majority of amenorrhea cases are caused by four conditions, which include polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.
- Common complications of amenorrhea from PCOS include:
- Hyperprolactinemia leads to galactorrhea, decreased libido, and pregnancy complications. In case of prolactin-producing pituitary adenoma, massive enlargement of the tumor may affect vision and pituitary function. It can also cause osteopenia and osteoporosis in pre-menopausal women.[5]
- Common complications of premature ovarian failure are infertility, osteoporosis, depression/anxiety, cardiac disease, and dementia.[6]
- Patients with hypothalamic (functional) amenorrhea experience various complications, such as infertility, decrease in bone mineral density (BMD), increased risk for fracture, along with cardiovascular and psychological problems.[2]
- The most important complication of premature ovarian failure is infertility, that is preventable to some extent with appropriate therapies. Bone loss and mental problems are other complications.[7]
Prognosis
- Prognosis is generally excellent and the mortality rate of patients with amenorrhea is approximately less than 1%.
- Among patients of androgen insensitivity syndrome there is an increased risk of testicular cancer, and surveillance should be done at appropriate intervals.
- Prognosis of polycystic ovary syndrome (PCOS) is generally good, long term diet and exercise along with metformin therapy decrease the cardiovascular and pregnancy problems in the future.[8]
- Long term (7 years) prognosis of hyperprolactinemia from microadenomas has 90-95% stability or gradual decrease in prolactin serum level. Whereas, one third of patients with idiopathic hyperprolactinemia are cured without therapy, two thirds of patients with macroadenomas and basal prolactin < 40 ng/mL. 40% of relapse within 5 years after surgery.[9]
References
- ↑ Palomba S, Santagni S, Falbo A, La Sala GB (2015). "Complications and challenges associated with polycystic ovary syndrome: current perspectives". Int J Womens Health. 7: 745–63. doi:10.2147/IJWH.S70314. PMC 4527566. PMID 26261426.
- ↑ 2.0 2.1 Meczekalski B, Katulski K, Czyzyk A, Podfigurna-Stopa A, Maciejewska-Jeske M (2014) Functional hypothalamic amenorrhea and its influence on women's health. J Endocrinol Invest 37 (11):1049-56. DOI:10.1007/s40618-014-0169-3 PMID: 25201001
- ↑ Vegetti W, Marozzi A, Manfredini E, Testa G, Alagna F, Nicolosi A, Caliari I, Taborelli M, Tibiletti MG, Dalprà L, Crosignani PG (2000). "Premature ovarian failure". Mol. Cell. Endocrinol. 161 (1–2): 53–7. PMID 10773392.
- ↑ Mattei AM, Severini V, Crosignani PG (1991). "Natural history of hyperprolactinemia". Ann. N. Y. Acad. Sci. 626: 130–6. PMID 2058949.
- ↑ Sanfilippo JS (1999). "Implications of not treating hyperprolactinemia". J Reprod Med. 44 (12 Suppl): 1111–5. PMID 10649820.
- ↑ "Premature ovarian failure - Symptoms and causes - Mayo Clinic".
- ↑ Nelson LM (2009). "Clinical practice. Primary ovarian insufficiency". N Engl J Med. 360 (6): 606–14. doi:10.1056/NEJMcp0808697. PMC 2762081. PMID 19196677.
- ↑ Hart R (2007). "Polycystic ovarian syndrome--prognosis and treatment outcomes". Curr. Opin. Obstet. Gynecol. 19 (6): 529–35. doi:10.1097/GCO.0b013e3282f10e22. PMID 18007129.
- ↑ "Hyperprolactinemia Follow-up: Further Outpatient Care, Complications, Prognosis".